Zheling Chen

1.2k total citations
44 papers, 791 citations indexed

About

Zheling Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zheling Chen has authored 44 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Zheling Chen's work include Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Zheling Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Zheling Chen collaborates with scholars based in China, United States and Canada. Zheling Chen's co-authors include Jiao Yang, Meng Lv, Yanwei Shen, Shuting Li, Pan Li, Mengying Wang, Yang Jin, Shuting Li, Min Yi and Biyuan Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Zheling Chen

39 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zheling Chen China	15	378	280	214	196	162	44	791
Gregory Idos United States	16	457 1.2×	446 1.6×	166 0.8×	121 0.6×	195 1.2×	51	960
Anna Schmitt Germany	13	418 1.1×	451 1.6×	195 0.9×	89 0.5×	167 1.0×	22	828
Bojan Losic United States	8	381 1.0×	298 1.1×	278 1.3×	262 1.3×	101 0.6×	13	901
Chang‐Jun Tan China	14	180 0.5×	224 0.8×	168 0.8×	99 0.5×	109 0.7×	28	706
Laia Bassaganyas Spain	13	415 1.1×	380 1.4×	324 1.5×	313 1.6×	140 0.9×	22	1.1k
Floris H. Groenendijk Netherlands	13	234 0.6×	316 1.1×	281 1.3×	204 1.0×	67 0.4×	27	815
Ensel Oh South Korea	17	323 0.9×	397 1.4×	263 1.2×	247 1.3×	86 0.5×	26	806
Emanuela Balladore Italy	8	405 1.1×	272 1.0×	132 0.6×	67 0.3×	92 0.6×	14	771
Katsuharu Saito Japan	19	388 1.0×	361 1.3×	159 0.7×	145 0.7×	127 0.8×	36	760
Hein F.B.M. Sleddens Netherlands	15	313 0.8×	357 1.3×	231 1.1×	173 0.9×	189 1.2×	22	782

Countries citing papers authored by Zheling Chen

Since Specialization

Citations

This map shows the geographic impact of Zheling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheling Chen more than expected).

Fields of papers citing papers by Zheling Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheling Chen. The network helps show where Zheling Chen may publish in the future.

Co-authorship network of co-authors of Zheling Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zheling Chen. A scholar is included among the top collaborators of Zheling Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheling Chen. Zheling Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ke, Bo Jiang, Huiping Yan, Yang Liu, & Zheling Chen. (2025). Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review. Frontiers in Oncology. 15. 1395129–1395129. 1 indexed citations

Chen, Zheling, Yu Cai, Kui-Dong Zhao, et al.. (2025). A novel oncolytic poxvirus carrying CD47 nanomabs in the treatment of pancreatic cancer by reshaping the immune microenvironment. Cancer Letters. 632. 217934–217934.

Jiang, Jiahong, et al.. (2025). Anticancer therapy-induced peripheral neuropathy in solid tumors: diagnosis, mechanisms, and treatment strategies. Cancer Letters. 620. 217679–217679. 1 indexed citations

Chen, Zheling, et al.. (2025). The depression-heart connection: cardiovascular risks in cancer patients from NHANES 2005–2018. BMC Psychiatry. 25(1). 302–302.

Liu, Yang, et al.. (2024). Erythrocyte-αPD-1 conjugates overcome resistance to checkpoint blockade immunotherapy: A first-in-human study.. Journal of Clinical Oncology. 42(16_suppl). 2557–2557. 1 indexed citations

Zhu, Pengfei, et al.. (2023). Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study. World Journal of Surgical Oncology. 21(1). 129–129. 3 indexed citations

Zhu, Pengfei, et al.. (2023). Predictive value of NLR and PLR for immune-related adverse events: a systematic review and meta-analysis. Clinical & Translational Oncology. 26(5). 1106–1116. 10 indexed citations

Zhang, Xinyue, et al.. (2023). Comparison of the efficacy and safety of fruquintinib and regorafenib in the treatment of metastatic colorectal cancer: A real-world study. Frontiers in Oncology. 13. 1097911–1097911. 14 indexed citations

Wang, Mingxing, et al.. (2023). Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer—a case report and literature review. Translational Cancer Research. 12(1). 177–185. 5 indexed citations

10.

Jiang, Jiahong, Yaping Xu, Lianpeng Chang, et al.. (2021). Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 771247–771247. 1 indexed citations

11.

Yang, Jiao, Xiaoman Zhang, Zheling Chen, et al.. (2019). Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer. Cell Death and Disease. 10(3). 179–179. 14 indexed citations

12.

Yang, Jiao, et al.. (2019). The potential markers of endocrine resistance among HR+ /HER2+ breast cancer patients. Clinical & Translational Oncology. 22(4). 576–584. 15 indexed citations

13.

Chen, Ke, Yucheng Zhou, Weiwei Jin, et al.. (2019). Laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic outcomes and long-term survival. Surgical Endoscopy. 34(5). 1948–1958. 26 indexed citations

14.

Chen, Zheling, Jiao Yang, Yanwei Shen, et al.. (2018). AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility. Journal of Cellular and Molecular Medicine. 22(4). 2390–2403. 6 indexed citations

15.

Wang, Biyuan, Jiao Yang, Shuting Li, et al.. (2017). Tumor location as a novel high risk parameter for stage II colorectal cancers. PLoS ONE. 12(6). e0179910–e0179910. 24 indexed citations

16.

Chen, Zheling, Jiao Yang, Shuting Li, et al.. (2017). Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma. PLoS ONE. 12(9). e0182397–e0182397. 107 indexed citations

17.

Li, Shuting, Jiao Yang, Meng Lv, et al.. (2017). Clinicopathological features and survival of early stage breast cancer in northwest China: A population‐based retrospective study of 1287 patients. Thoracic Cancer. 9(1). 10–18. 10 indexed citations

18.

Lv, Meng, Xiao Zhang, Yanwei Shen, et al.. (2017). Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine. 96(17). e6799–e6799. 77 indexed citations

19.

Yang, Jiao, Shuting Li, Meng Lv, et al.. (2017). Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study. OncoTargets and Therapy. Volume 10. 1535–1548. 13 indexed citations

20.

Yang, Jiao, Shuting Li, Biyuan Wang, et al.. (2016). Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer. Tumor Biology. 37(9). 11645–11655. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact